These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34847941)
1. Differences in ICSI utilization rates among states with insurance mandates for ART coverage. Zagadailov P; Cho KS; Seifer DB Reprod Biol Endocrinol; 2021 Nov; 19(1):174. PubMed ID: 34847941 [TBL] [Abstract][Full Text] [Related]
2. Do state insurance mandates alter ICSI utilization? Zagadailov P; Seifer DB; Shan H; Zarek SM; Hsu AL Reprod Biol Endocrinol; 2020 Apr; 18(1):33. PubMed ID: 32334609 [TBL] [Abstract][Full Text] [Related]
3. Association of state insurance coverage mandates with assisted reproductive technology care discontinuation. Lee JC; DeSantis CE; Yartel AK; Kissin DM; Kawwass JF Am J Obstet Gynecol; 2023 Mar; 228(3):315.e1-315.e14. PubMed ID: 36368429 [TBL] [Abstract][Full Text] [Related]
4. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States. Peipert BJ; Chung EH; Harris BS; Jain T Am J Obstet Gynecol; 2022 Jul; 227(1):64.e1-64.e8. PubMed ID: 35283088 [TBL] [Abstract][Full Text] [Related]
5. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Dieke AC; Mehta A; Kissin DM; Nangia AK; Warner L; Boulet SL Fertil Steril; 2018 Apr; 109(4):691-697. PubMed ID: 29580644 [TBL] [Abstract][Full Text] [Related]
6. Trends in the use of intracytoplasmic sperm injection in the United States. Jain T; Gupta RS N Engl J Med; 2007 Jul; 357(3):251-7. PubMed ID: 17634460 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Butts SF; Ratcliffe S; Dokras A; Seifer DB Fertil Steril; 2013 Feb; 99(2):382-8. PubMed ID: 23102859 [TBL] [Abstract][Full Text] [Related]
9. State insurance mandates and racial and ethnic inequities in assisted reproductive technology utilization. Korkidakis A; DeSantis C; Kissin D; Hacker M; Koniares K; Yartel A; Adashi E; Penzias A; Fertil Steril; 2024 Jan; 121(1):54-62. PubMed ID: 37775023 [TBL] [Abstract][Full Text] [Related]
10. The impact of insurance mandates on donor oocyte utilization: an analysis of 39,338 donor oocyte cycles from the Society for Assisted Reproductive Technology registry. George JS; Lee MS; Ashby RK; Goldman R; Ginsburg ES; Lanes A; Srouji SS Am J Obstet Gynecol; 2022 Dec; 227(6):877.e1-877.e11. PubMed ID: 35863456 [TBL] [Abstract][Full Text] [Related]
11. Disparities in Assisted Reproductive Technology Utilization by Race and Ethnicity, United States, 2014: A Commentary. Dieke AC; Zhang Y; Kissin DM; Barfield WD; Boulet SL J Womens Health (Larchmt); 2017 Jun; 26(6):605-608. PubMed ID: 28586255 [TBL] [Abstract][Full Text] [Related]
12. Temporal Differences in Utilization of Intracytoplasmic Sperm Injection Among U.S. Regions. Zagadailov P; Hsu A; Stern JE; Seifer DB Obstet Gynecol; 2018 Aug; 132(2):310-320. PubMed ID: 29995722 [TBL] [Abstract][Full Text] [Related]
17. In vitro fertilization and multiple pregnancies: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488 [TBL] [Abstract][Full Text] [Related]